Concord Biotech Limited (CONCORDBIO.BO)

INR 2153.4

(-1.05%)

Operating Income Summary of Concord Biotech Limited

  • Concord Biotech Limited's latest annual operating income in 2023 was 6.26 Billion INR , up 35.54% from previous year.
  • Concord Biotech Limited's latest quarterly operating income in 2024 Q1 was 681 Million INR , up 12.66% from previous quarter.
  • Concord Biotech Limited reported an annual operating income of 2.78 Billion INR in 2022, up 24.35% from previous year.
  • Concord Biotech Limited reported an annual operating income of 2.24 Billion INR in 2021, down -23.48% from previous year.
  • Concord Biotech Limited reported a quarterly operating income of 3.77 Billion INR for 2023 FY, up 35.54% from previous quarter.
  • Concord Biotech Limited reported a quarterly operating income of 923.91 Million INR for 2023 Q3, down -12.75% from previous quarter.

Annual Operating Income Chart of Concord Biotech Limited (2023 - 2019)

Historical Annual Operating Income of Concord Biotech Limited (2023 - 2019)

Year Operating Income Operating Income Growth
2023 6.26 Billion INR 35.54%
2022 2.78 Billion INR 24.35%
2021 2.24 Billion INR -23.48%
2020 2.93 Billion INR 59.98%
2019 1.83 Billion INR 0.0%

Peer Operating Income Comparison of Concord Biotech Limited

Name Operating Income Operating Income Difference
Alfavision Overseas (India) Limited 9.28 Million INR -67355.047%
Biocon Limited 50.83 Billion INR 87.681%
Blue Jet Healthcare Limited 3.37 Billion INR -85.689%
Dishman Carbogen Amcis Limited -13.9 Million INR 45149.295%
FERMENTA BIOTECH LIMITED 1.06 Billion INR -486.345%
GENOMIC VALLEY BIOTECH LIMITED 1.27 Million INR -490736.919%
Lyka Labs Limited 29.13 Million INR -21396.231%
Panacea Biotec Limited -309.7 Million INR 2121.909%
SAMSRITA LABS LIMITED -1.49 Million INR 418287.234%
Servoteach Industries Limited -785.00 INR 797688252.866%
SMS Lifesciences India Limited 359.47 Million INR -1641.958%
Supriya Lifescience Limited 1.57 Billion INR -298.425%
Syngene International Limited 14.02 Billion INR 55.352%
TAKE Solutions Limited -213.49 Million INR 3033.089%
Titan Biotech Limited 315.89 Million INR -1882.239%
Transgene Biotek Limited -7.08 Million INR 88431.951%
Vanta Bioscience Limited -31.83 Million INR 19767.856%